Marinus Pharmaceuticals has announced that its pivotal Phase III RAISE study (NCT04391569) of IV ganaxolone for the treatment of status epilepticus (SE) has failed to meet its pre-defined early ...

Nonconvulsive status epilepticus (NCSE) encompasses a wide range of diagnoses with variable outcomes and treatment recommendations. In children, NCSE can be observed in various conditions ...

For informational purposes only. Consult a medical professional for advice. Source: Focus Medica Epilepsy is a group of non-communicable neurological disorders characterized by recurrent epileptic ...